PharVision Advisers’s Whitestone REIT WSR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,229
Closed -$170K 657
2025
Q4
$170K Sell
12,229
-15,259
-56% -$197K 0.09% 598
2025
Q3
$338K Buy
+27,488
New +$346K 0.19% 160
2025
Q2
Sell
-36,471
Closed -$531K 448
2025
Q1
$531K Buy
36,471
+22,232
+156% +$306K 0.74% 11
2024
Q4
$202K Buy
+14,239
New +$203K 0.17% 306

Other funds holding WSR

PharVision Advisers's WSR Position: Q1 2026 in Review

PharVision Advisers sold out of Whitestone REIT (WSR) in Q1 2026, closing a stake of 12,229 shares — an estimated $170K sold.

PharVision Advisers first reported a position in WSR in Q4 2024 and held it in 4 quarters. The position peaked at $531K in Q1 2025. 220 funds tracked by Wall St. Rank hold WSR as of Q1 2026.

  • PharVision Advisers reported no remaining Whitestone REIT position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 12,229 Whitestone REIT shares in Q1 2026, an estimated $170K.
  • PharVision Advisers first reported a position in Whitestone REIT in Q4 2024 and held it in 4 quarters.
  • PharVision Advisers's Whitestone REIT position peaked at $531K in Q1 2025.
  • 220 funds tracked by Wall St. Rank held Whitestone REIT as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.